The development of genetic transformation technology for plants has stimulated an interest in using transgenic plants as a novel manufacturing system for producing different classes of proteins of industrial and pharmaceutical value. In this regard, we report the generation and characterization of transgenic maize lines producing recombinant aprotinin. The transgenic aprotinin lines recovered were transformed with the aprotinin gene using the bar gene as a selectable marker. The bar and aprotinin genes were introduced into immature maize embryos via particle bombardment. Aprotinin gene expression was driven by the maize ubiquitin promoter and protein accumulation was targeted to the extracellular matrix. One line that showed a high level of aprotinin expression was characterized in detail. The protein accumulates primarily in the embryo of the seed. Southern blot analysis showed that the line had at least 20 copies of the bar and aprotinin genes. Further genetic analysis revealed that numerous plants derived from this transgenic line had a large range of levels of expression of the aprotinin gene (0–0.069%) of water-soluble protein in T2 seeds. One plant lineage that showed stable expression after 4 selfing generations was recovered from the parental transgenic line. This line showed an accumulation of the protein in seeds that was comparable to the best T2 lines, and the recombinant aprotinin could be effectively recovered and purified from seeds. Biochemical analysis of the purified aprotinin from seeds revealed that the recombinant aprotinin had the same molecular weight, N-terminal amino acid sequence, isoelectric point, and trypsin inhibition activity as native aprotinin. The demonstration that the recombinant aprotinin protein purified from transgenic maize seeds has biochemical and functional properties identical to its native counterpart provides a proof-of-concept example for producing new generation products for the pharmaceutical industry.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
An G, Mitra A, Choi HK, Costa MA, An K, Thomburg RW, Ryan CA: Functional analysis of the 30 control region of the potato wound-inducible proteinase inhibitor II gene. Plant Cell 1: 115–122 (1989).
Anderson S, Kingston IB: Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique sequence synthetic DNA probe. Proc Natl Acad Sci USA 80: 6838–6842 (1983).
Armstrong CL, Green CE, Phillips RL: Development and availability of germplasm with high Type II culture formation response. Maize Genet Coop Newsl. 65: 92–93 (1991).
Austin S, Bingham ET, Koegel RG, Mathews DE, Shahan NW, Straub RJ, Burgess RR: An overview of a feasibility study for the production of industrial enzymes in transgenic alfalfa. Ann NY Acad Sci 721: 234–244 (1994).
Balabushevitch NG, Kildeyeva NR, Moroz NA, Trusova SP, Vimik AD, Khromov GL, Larionova NL: Regulating aspects of biosoluble and insoluble film release systems containing protein proteinase inhibitor. Appl Biochem Biotechnol 61: 129–138 (1996).
Benfey PN, Chua N-H: Regulated genes in transgenic plants. Science 244: 174–181 (1989).
Bradford M: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254 (1976).
Davies MJ, Allen A, Kort H, Weerasena NA, Rocco D, Paul CL, Hunt BJ, Elliott MJ: Prospective, randomized, doubleblind study of high-dose aprotinin in pediatric cardiac operations. Ann Thoracic Surg 63: 497–503 (1997).
Finnegan J, McElroy D: Transgene inactivation: plants fight back! Bio/technology 12: 883–888 (1994).
Fisk HJ, Dandekar AM: The introduction and expression of transgenes in plants. Scient Hort 55: 5–36 (1993).
Flavell RB: Inactivation of gene expression in plants as a consequence of novel sequence duplications. Proc Natl Acad Sci USA 91: 3490–3496 (1994).
Franken E, Teuschel U, Hain R: Recombinant proteins from transgenic plants. Curr Opin Biotechonol 8: 411–416 (1997).
Gallie DR, Sleat DE, Watts JW, Turner PC, Wilson TMA: The 50-leader sequence of tobacco mosaic virus RNA enhances the expression of foreign gene transcripts in vitro and in vivo. Nucl Acids Res 15: 3257–3273 (1987).
Hood EE, Witcher D, Maddock S, Meyer T, Baszczynski C, Bailey M, Flynn P, Register J, Marshall L. Bond D, Kulisek E, Kusnadi A, Kusnadi A, Evangelista R, Nikolov Z, Wooge C, Mehigh R, Hennan R, Heman R, Kappel W, Ritland D, Li C-P, Howard J: Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extracting and purification. Mol Breed 3: 291–306 (1997).
Iglesias VA, Moscone EA, Papp I, Neuhuber F, Michalowski S, Phelan T, Spiker S, Matzke M, Matzke AJM: Molecu-lar and cytogenctic analysis of stable and unstably expressed transgene loci in tobacco. Plant Cell 9: 1251–1264 (1997).
Jefferey M, Goodbrand JM, Goodsir CM: Pathology of the transmissible spongiform encephalopathies with special emphasis on ultrastructure. Micron 26: 277–298 (1995).
Krebbers E, Bosch D, Vandekekerckhove J: Prospects and progress in the production of foreign proteins and peptides in plants. In: Shewry PR, Gutteridge S (eds) Plant Protein Engineering, pp. 315–325. Cambridge University Press, Cambridge, UK (1993).
Laskowski M, Kato I: Protein inhibitors of proteinases. Ann Rev Biochem 49: 593--626 (1980).
Matzke MA, Matzke AJM: How and why do plants inactivate homologous (trans)genes? Plant Physiol 107: 679–685 (1995).
Meyer P: Repeat-induced gene silencing: common mechanisms in plants and fungi. Biol Chem Hoppe-Seyler 377: 87–95 (1996).
Miele L: Plants as bioreactors for biopharmaceuticals: regulatory considerations. Trends Biotechnol 15: 45–50 (1997).
Nagy F, Odell JT, Morelli, G, Chua NH: Properties of expression of the 35S promoter from CAMV in transgenic tobacco plants. In: Zaitlin M, Day P, Hollaender A (eds) Biotechnology in Plant Science: Relevance to Agriculture in the Eighties, pp. 227–235. Academic Press, Orlando, FL (1985).
Pen J, Sijmons PC, van Ooijen AJJ, Hockema A: Protein production in transgenic crops: analysis of plant molecular farming. In: Industrial Crops Production, pp. 241–250. Elsevier, Amsterdam (1993).
Register JC, Peterson DJ, Bell PJ, Bullock WP, Evans IJ, Frame B, Greenland AJ, Higgs NS, Jepson I, Jiao S: Structure and function of selectable and nonselectable transgenes in maize after introduction by particle bombardment. Plant Mol Biol 25: 951–961 (1994).
Rogers JC: Two barley _-amylase gene families are regulated differently in aleurone cells. J Biol Chem 260: 3731–3738 (1985).
Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
Schaegger and von Jagow: Tricine- sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368–379 (1987).
Smith C, Collings J: Molecular pathology of prion disease. Essays Biochem 29: 157–174 (1995).
Stam M, Mol JNM, Kooter JM: The silencing of genes in transgenic plants. Ann Bot 79: 3–12 (1997).
Tomes DT, Ross MC, Songstad DD: Direct DNA transfer into intact plant cells via microprojectile bombardment. In: Gamborg OL, Phillips GC (eds) Plant Cell Tissue and Organ Culture: Fundamental Methods, pp. 197–213. Springer-Verlag, Berlin/Heidelberg (1995).
White J, Chang S-YP, Bibb MJ, Bibb MJ: A cassette containing the bar gene of Streptomyces hygroscopicus: a selectable marker for plant transformation. Nucl Acids Res 18: 1062 (1990).
Whitelam GC, Cockbum W: Antibody expression in transgenic plants. Trends Plant Sci 1: 268–272 (1996).
Whitelam GC, Cockbum B, Gandecha AR, Owen MRL: Heterologous protein production in transgenic plants. Biotechnol Genet Engng Rev 11: 1–29 (1993).
Witcher DR, DeWaard M, Liu H, Pragnell M, Campbell KP: Association of native Ca2 +C channel β subunits with the α 1 subunit interaction domain. J Biol Chem 270: 18088–18093 (1995).
Witcher DR, Hood EE, Peterson D, Bailey M, Marshall L, Bond D, Ritland D, Kusnadi A, Evangelista R, Nikolov Z, Wooge C, Mehigh R, Kappel B, Register J, Howard J: Commercial production of β-glucuronidase (GUS): amodel system for the production of proteins in plants. Mol Breed 4: 301–312 (1998).
About this article
Cite this article
Zhong, GY., Peterson, D., Delaney, D.E. et al. Commercial production of aprotinin in transgenic maize seeds. Molecular Breeding 5, 345–356 (1999). https://doi.org/10.1023/A:1009677809492
- heterologous protein
- transgenic maize
- pharmaceutical protein
- transgene genetics
- transgene stability